BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34703647)

  • 21. LINC01311 exerts an inhibitory effect in thyroid cancer progression by targeting the miR-146b-5p/IMPA2 axis.
    Liu M; Zhang L; Hu J; Yan C; Zhang Y; Yan Z
    Transl Oncol; 2023 Jan; 27():101588. PubMed ID: 36423383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
    Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
    Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
    Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
    Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence.
    Zhen S; Jia Y; Zhao Y; Wang J; Zheng B; Liu T; Duan Y; Lv W; Wang J; Xu F; Liu Y; Zhang Y; Liu L
    Cell Death Discov; 2024 Mar; 10(1):131. PubMed ID: 38472205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma.
    Li W; Pan T; Jiang W; Zhao H
    Biomed Pharmacother; 2020 Sep; 129():110217. PubMed ID: 32559619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1.
    Wang M; Liao Q; Zou P
    Cancer Biol Ther; 2020 Apr; 21(4):364-371. PubMed ID: 31939714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA FGF14-AS2 represses proliferation, migration, invasion, and induces apoptosis in breast cancer by sponging miR-205-5p.
    Yang Y; Xun N; Wu JG
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6971-6982. PubMed ID: 31486497
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long noncoding RNA HIF1A-AS2 facilitates cisplatin resistance in bladder cancer.
    Chen X; Liu M; Meng F; Sun B; Jin X; Jia C
    J Cell Biochem; 2019 Jan; 120(1):243-252. PubMed ID: 30216500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomal microRNA-26b-5p down-regulates ATF2 to enhance radiosensitivity of lung adenocarcinoma cells.
    Han F; Huang D; Huang X; Wang W; Yang S; Chen S
    J Cell Mol Med; 2020 Jul; 24(14):7730-7742. PubMed ID: 32476275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. lncRNAs HIF1A-AS2 facilitates the up-regulation of HIF-1α by sponging to miR-153-3p, whereby promoting angiogenesis in HUVECs in hypoxia.
    Li L; Wang M; Mei Z; Cao W; Yang Y; Wang Y; Wen A
    Biomed Pharmacother; 2017 Dec; 96():165-172. PubMed ID: 28985553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense Long Noncoding RNA HIF1A-AS2 Is Upregulated in Gastric Cancer and Associated with Poor Prognosis.
    Chen WM; Huang MD; Kong R; Xu TP; Zhang EB; Xia R; Sun M; De W; Shu YQ
    Dig Dis Sci; 2015 Jun; 60(6):1655-62. PubMed ID: 25686741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway.
    Zheng X; Zhang J; Fang T; Wang X; Wang S; Ma Z; Xu Y; Han C; Sun M; Xu L; Wang J; Yin R
    Oncogenesis; 2020 Mar; 9(3):34. PubMed ID: 32165621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-125b-5p Correlates With Prognosis and Lung Adenocarcinoma Progression.
    Tang L; Yuan Y; Zhai H; Wang J; Zhang D; Liang H; Shi Y; Duan L; Jiang X
    Front Mol Biosci; 2021; 8():788690. PubMed ID: 35187068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3.
    Zhao X; Li X; Zhou L; Ni J; Yan W; Ma R; Wu J; Feng J; Chen P
    Cancer Sci; 2018 Oct; 109(10):3068-3079. PubMed ID: 30099826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
    Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
    Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulating Long Non-coding RNAs CTBP1-AS2 Inhibits Colorectal Cancer Development by Modulating the miR-93-5p/TGF-β/SMAD2/3 Pathway.
    Li Q; Yue W; Li M; Jiang Z; Hou Z; Liu W; Ma N; Gan W; Li Y; Zhou T; Yue W; Chen S
    Front Oncol; 2021; 11():626620. PubMed ID: 33937030
    [No Abstract]   [Full Text] [Related]  

  • 38. LncRNA HOXA-AS2 Facilitates Tumorigenesis and Progression of Papillary Thyroid Cancer by Modulating the miR-15a-5p/HOXA3 Axis.
    Jiang L; Wu Z; Meng X; Chu X; Huang H; Xu C
    Hum Gene Ther; 2019 May; 30(5):618-631. PubMed ID: 30375256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
    Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
    Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling.
    Zhao M; Xin XF; Zhang JY; Dai W; Lv TF; Song Y
    Cancer Med; 2020 Feb; 9(3):1196-1208. PubMed ID: 31860169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.